Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluating Patient Safety and Efficacy of Robot-Assisted Adrenalectomy: 90-Day Outcomes.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

Same author

Post-transplant metabolic dysregulation: Insights and implications for kidney graft survival.

World journal of nephrology·2026

Same author

Lupus nephritis and kidney transplantation: A narrative review of patient and graft outcomes.

World journal of nephrology·2026

Same author

Male infertility in lupus nephritis: Clinical implications and management strategies.

Lupus·2026

Same author

IgA-Dominant Idiopathic Membranoproliferative Glomerulonephritis: Insights into Clinicopathological Characteristics and Kidney Outcomes in a Developing Country.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026

Same author

Hypoalbuminemia as a predictor of mortality in patients with acute cholangitis: A systematic review and meta-analysis.

World journal of gastrointestinal pathophysiology·2026

Search research articles

Related Experiment Video

Updated: May 12, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

IgM nephropathy revisited.

Muhammed Mubarak¹, Javed I Kazi

¹Histopathology Department, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.

Nephro-Urology Monthly

|April 11, 2013

Summary

IgM nephropathy (IgMN) is an immune complex-mediated glomerulopathy. Despite its 1978 description, research lagged, but recent studies from tropical countries show renewed interest, highlighting a need for better diagnostic criteria and mechanistic studies.

Area of Science:

Nephrology
Immunology
Pathology

Background:

IgM nephropathy (IgMN) is an idiopathic immune complex-mediated glomerulopathy.
First described in 1978, IgMN has seen fluctuating research interest.
Recent studies, particularly from tropical regions, have reignited focus on IgMN.

Purpose of the Study:

To present a historical review and current status of IgM nephropathy.
To critically analyze existing world literature on IgMN.
To identify gaps in IgMN research and suggest future directions.

Main Methods:

A comprehensive literature search was conducted on PubMed.
Articles focusing on IgMN or including significant IgMN case series were selected.
A critical review of the selected 41 English-language articles was performed.

Keywords:

Kidney Diseases Nephrotic Syndrome Pathology

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6^th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Related Experiment Videos

Last Updated: May 12, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6^th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Main Results:

Initial reports post-1978 were primarily from Western countries.
Substantial basic research on IgMN was limited for decades.
Recent literature shows increased publications, predominantly from tropical countries.

Conclusions:

IgM nephropathy research has historically been neglected, especially in Western countries.
Current literature predominantly relies on clinical observations, lacking experimental and mechanistic studies.
There is an urgent need for consensus diagnostic criteria and focused research into IgMN pathogenesis.